Alamar Biosciences Cash Flow Statement
NASDAQ: ALMRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alamar Biosciences has no annual cash flow statement on file yet, so quarterly figures are shown instead.
Alamar Biosciences free cash flow
In the quarter ended Jun 30, 2026, Alamar Biosciences generated -$11.3 million of operating cash flow and spent $3.6 million on capital expenditures. That left free cash flow of -$15.0 million, a free-cash-flow margin of -50.9% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Alamar Biosciences cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Net Income | -13.20M | -21.32M | -7.02M | -7.66M |
| Net Income growth (YoY) | — | — | — | — |
| Depreciation & Amortization | 1.13M | 1.17M | 919.00K | 888.00K |
| Stock-Based Compensation | 3.28M | 1.47M | 680.00K | 619.00K |
| Change in Working Capital | -1.27M | -8.74M | -11.03M | -2.12M |
| Operating Cash Flow | -11.32M | -20.35M | -11.88M | -13.07M |
| Capital Expenditures | -3.64M | -600.00K | -753.00K | -554.00K |
| Investing Cash Flow | -120.80M | -778.00K | 17.95M | 17.02M |
| Financing Cash Flow | 201.84M | 55.76M | 164.00K | 243.00K |
| Net Change in Cash | 69.73M | 34.58M | 6.56M | 4.33M |
| Free Cash Flow | -14.96M | -20.95M | -12.63M | -13.62M |
This table shows 4 quarterly periods of Alamar Biosciences's cash flow statement, from Q2 2026 back to Q? 2025, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ALMR's reporting calendar. What is a cash flow statement?